Hemolytic disease of the newborn (HDN), also known as erythroblastosis fetalis, is a serious condition in which a mother’s immune system attacks the red blood cells of her fetus. This immune-mediated hemolysis can lead to anemia, jaundice, heart failure, or even fetal death. Understanding the pathophysiology of hemolytic disease of the newborn is essential for preventing and managing this life-threatening disorder.
Get a Well-Crafted Paper at WritersProHub
Struggling with complex topics in pathophysiology or obstetrics? WritersProHub delivers accurate, well-researched academic content for nursing and medical students. Contact us today for original papers on HDN, immune responses, or maternal-fetal health!
1. Cause: Rh Incompatibility
The most common cause of HDN is Rh incompatibility between a mother and fetus.
- Mother: Rh-negative (lacks D antigen)
- Fetus: Rh-positive (inherits D antigen from father)
During pregnancy or delivery, small amounts of fetal blood may enter the maternal circulation, especially:
- During childbirth
- Miscarriage
- Trauma or procedures (e.g., amniocentesis)
2. Initial Immune Sensitization (First Pregnancy)
- The maternal immune system recognizes fetal Rh D antigens as foreign.
- B cells become sensitized and produce IgM antibodies, which do not cross the placenta.
- No harm to the first fetus typically occurs.
3. Secondary Immune Response (Subsequent Pregnancies)
- In later pregnancies with another Rh-positive fetus, memory B cells activate quickly.
- The mother produces IgG antibodies, which can cross the placenta.
4. Destruction of Fetal Red Blood Cells
The maternal anti-D IgG antibodies enter fetal circulation and bind to Rh D antigens on fetal red blood cells.
- This triggers immune-mediated hemolysis in the fetal spleen and liver.
- Fetal anemia develops, prompting increased production of immature RBCs (erythroblasts).
- The overproduction of erythroblasts gives the condition its alternate name: erythroblastosis fetalis.
5. Consequences of Hemolysis
A. Anemia and Hypoxia
- Leads to tissue oxygen deprivation
- May cause cardiac failure and hydrops fetalis (fetal edema)
B. Hyperbilirubinemia
- Excess breakdown of RBCs produces bilirubin
- In utero, maternal liver helps clear bilirubin
- After birth, infant’s liver may be unable to clear it, leading to jaundice and kernicterus (brain damage)
6. Prevention and Management
A. Rho(D) Immune Globulin (RhoGAM)
- Administered to Rh-negative mothers during pregnancy and after delivery
- Prevents sensitization by destroying fetal Rh-positive RBCs before maternal immune activation
B. Monitoring and Treatment
- Fetal monitoring with Doppler ultrasound and amniocentesis
- Intrauterine transfusions in severe anemia
- Postnatal care: phototherapy for jaundice, exchange transfusions if needed
Conclusion
The pathophysiology of hemolytic disease of the newborn involves maternal immune sensitization to fetal Rh D antigens, leading to IgG-mediated hemolysis of fetal red blood cells. Without intervention, this immune response can cause severe fetal anemia, jaundice, and even death. However, with modern prenatal screening and Rho(D) immune globulin therapy, HDN is largely preventable and manageable.
External Resources: